ロード中...
Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
We discuss the currently available data on the use of the prostacyclin mimetic selexipag in children and adolescents with pulmonary arterial hypertension (PAH). Future indications may include transitioning from intravenous prostacyclin/prostacyclin analog to oral selexipag, and vice versa, or adding...
保存先:
| 出版年: | Pulm Circ |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6161208/ https://ncbi.nlm.nih.gov/pubmed/30260767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894018793580 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|